期刊
EXPERIMENTAL CELL RESEARCH
卷 319, 期 2, 页码 160-169出版社
ELSEVIER INC
DOI: 10.1016/j.yexcr.2012.07.019
关键词
Epithelial-mesenchymal transitions (EMT); Cancer metastasis; DNA methylation; Histone modification; MicroRNA
资金
- National Natural Science Foundation of China [81130048, 90919053]
- 973 program from the Ministry of Science and Technology of China [2011CB504204]
Epithelial-mesenchymal transition (EMT) is vital for morphogenesis during embryonic development and is also critical for the conversion of early stage tumors into invasive malignancies. Several key inducers of EMT are transcription factors that repress the expression of E-cadherin, whose loss is a hallmark of EMT. Epigenetic regulation encompasses three types of changes: DNA methylation, histone modifications, and microRNAs, each of which has been shown to play a key role in controlling epithelial-mesenchymal transition and cancer metastasis. As we gain deeper understanding of epigenetic mechanisms controlling EMT processes and orchestrating all the metastatic steps, we broaden the therapeutic potentials of epigenetic drugs, such as DNA demethylating drugs and histone deacetylase/demethylase inhibitors, which can act upon metastasis-related genes, restoring their expression and biological functions. (c) 2012 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据